TY - JOUR T1 - Rebound stridor in children with croup after nebulised adrenaline: does it really exist? JF - Breathe JO - Breathe SP - e1 LP - e7 DO - 10.1183/20734735.0011-2019 VL - 15 IS - 1 AU - Muthukumar Sakthivel AU - Sami Elkashif AU - Khalid Al Ansari AU - Colin V.E. Powell Y1 - 2019/03/01 UR - http://breathe.ersjournals.com/content/15/1/e1.abstract N2 - Laryngotracheobronchitis is a common childhood illness affecting 3% of children. Most of the affected children are aged between 6 months and 3 years, with a peak incidence of 60 per 1000 child-years in those children aged between 1 and 2 years [1]. Epidemiological studies suggest that 1–5% of children with croup are admitted to hospital and 2–3% of those admitted children, require intubation [2]. Death is extremely rare and has been estimated to occur in no more than 1 in 30 000 cases [2]. Parainfluenza (types 1 and 3), and influenza A and B are the most common viral agents causing croup. Respiratory syncytial virus (RSV), rhinovirus, coronavirus, metapneumovirus and adenovirus are also responsible for this illness. There is seasonality to the prevalence with more presentations in the autumn. There is an annual pattern influenced by the variability of the viruses in the community for that year [2].Rebound stridor after the use of nebulised adrenaline does not exist http://ow.ly/aoOd30o5lEo ER -